Filana Therapeutics, Inc.
No trades
Fundamentals and stats
Operating, investing, and financing activities
Free cash flow for Q1 26 is −8.88 M USD. For 2025, it was −32.83 M USD and operating cash flow was −32.25 M USD.
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM